Ramanan, N.; Malik, M.-n.; Upneja, S.; Farooq, H.; Kulkarni, S.; Gupta, R.; Mathews, J.; Nasser, A.; Bocicariu, A.; Arayan, L.;
et al. Clinical Significance of Tumor Grade in Triple-Negative Breast Cancer: A Retrospective Cohort Analysis. Biomedicines 2025, 13, 1100.
https://doi.org/10.3390/biomedicines13051100
AMA Style
Ramanan N, Malik M-n, Upneja S, Farooq H, Kulkarni S, Gupta R, Mathews J, Nasser A, Bocicariu A, Arayan L,
et al. Clinical Significance of Tumor Grade in Triple-Negative Breast Cancer: A Retrospective Cohort Analysis. Biomedicines. 2025; 13(5):1100.
https://doi.org/10.3390/biomedicines13051100
Chicago/Turabian Style
Ramanan, Neya, Mah-noor Malik, Sarang Upneja, Haniya Farooq, Swati Kulkarni, Rasna Gupta, John Mathews, Abdullah Nasser, Alina Bocicariu, Laurice Arayan,
and et al. 2025. "Clinical Significance of Tumor Grade in Triple-Negative Breast Cancer: A Retrospective Cohort Analysis" Biomedicines 13, no. 5: 1100.
https://doi.org/10.3390/biomedicines13051100
APA Style
Ramanan, N., Malik, M.-n., Upneja, S., Farooq, H., Kulkarni, S., Gupta, R., Mathews, J., Nasser, A., Bocicariu, A., Arayan, L., Porter, L., Fifield, B.-A., Luo, R., Brackstone, M., & Hamm, C.
(2025). Clinical Significance of Tumor Grade in Triple-Negative Breast Cancer: A Retrospective Cohort Analysis. Biomedicines, 13(5), 1100.
https://doi.org/10.3390/biomedicines13051100
